These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

150 related articles for article (PubMed ID: 18648767)

  • 1. Secretory phospholipase A2 and neonatal respiratory distress: pilot study on broncho-alveolar lavage.
    De Luca D; Baroni S; Vento G; Piastra M; Pietrini D; Romitelli F; Capoluongo E; Romagnoli C; Conti G; Zecca E
    Intensive Care Med; 2008 Oct; 34(10):1858-64. PubMed ID: 18648767
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Varespladib inhibits secretory phospholipase A2 in bronchoalveolar lavage of different types of neonatal lung injury.
    De Luca D; Minucci A; Trias J; Tripodi D; Conti G; Zuppi C; Capoluongo E;
    J Clin Pharmacol; 2012 May; 52(5):729-37. PubMed ID: 21602519
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Secretory phospholipase A2 pathway in various types of lung injury in neonates and infants: a multicentre translational study.
    De Luca D; Capoluongo E; Rigo V;
    BMC Pediatr; 2011 Nov; 11():101. PubMed ID: 22067747
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Surfactant-secreted phospholipase A
    De Luca D; Shankar-Aguilera S; Autilio C; Raschetti R; Vedovelli L; Fitting C; Payré C; Jeammet L; Perez-Gil J; Cogo PE; Carnielli VP; Lambeau G; Touqui L
    Am J Physiol Lung Cell Mol Physiol; 2020 Jul; 319(1):L95-L104. PubMed ID: 32401671
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Role of distinct phospholipases A2 and their modulators in meconium aspiration syndrome in human neonates.
    De Luca D; Minucci A; Tripodi D; Piastra M; Pietrini D; Zuppi C; Conti G; Carnielli VP; Capoluongo E
    Intensive Care Med; 2011 Jul; 37(7):1158-65. PubMed ID: 21567110
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Bile acids cause secretory phospholipase A2 activity enhancement, revertible by exogenous surfactant administration.
    De Luca D; Minucci A; Zecca E; Piastra M; Pietrini D; Carnielli VP; Zuppi C; Tridente A; Conti G; Capoluongo ED
    Intensive Care Med; 2009 Feb; 35(2):321-6. PubMed ID: 18853138
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Early life surfactant protein-D levels in bronchoalveolar lavage fluids of extremely preterm neonates.
    De Luca D; Arroyo R; Foligno S; Autilio C; Touqui L; Kingma PS
    Am J Physiol Lung Cell Mol Physiol; 2023 Oct; 325(4):L411-L418. PubMed ID: 37489844
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Ex vivo effect of varespladib on secretory phospholipase A2 alveolar activity in infants with ARDS.
    De Luca D; Minucci A; Piastra M; Cogo PE; Vendittelli F; Marzano L; Gentile L; Giardina B; Conti G; Capoluongo ED
    PLoS One; 2012; 7(10):e47066. PubMed ID: 23071714
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Bile acid-induced lung injury in newborn infants: a bronchoalveolar lavage fluid study.
    Zecca E; De Luca D; Baroni S; Vento G; Tiberi E; Romagnoli C
    Pediatrics; 2008 Jan; 121(1):e146-9. PubMed ID: 18166532
    [TBL] [Abstract][Full Text] [Related]  

  • 10. 18:1/18:1-Dioleoyl-phosphatidylglycerol prevents alveolar epithelial apoptosis and profibrotic stimulus in a neonatal piglet model of acute respiratory distress syndrome.
    Preuß S; Scheiermann J; Stadelmann S; Omam FD; Winoto-Morbach S; Lex D; von Bismarck P; Adam-Klages S; Knerlich-Lukoschus F; Wesch D; Held-Feindt J; Uhlig S; Schütze S; Krause MF
    Pulm Pharmacol Ther; 2014 Jun; 28(1):25-34. PubMed ID: 24140177
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Increased phospholipase A2 and lyso-phosphatidylcholine levels are associated with surfactant dysfunction in lung contusion injury in mice.
    Machado-Aranda D; Wang Z; Yu B; Suresh MV; Notter RH; Raghavendran K
    Surgery; 2013 Jan; 153(1):25-35. PubMed ID: 22853859
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Induction of type-IIA secretory phospholipase A2 in animal models of acute lung injury.
    Attalah HL; Wu Y; Alaoui-El-Azher M; Thouron F; Koumanov K; Wolf C; Brochard L; Harf A; Delclaux C; Touqui L
    Eur Respir J; 2003 Jun; 21(6):1040-5. PubMed ID: 12797501
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Serum Amyloid P Contained in Alveolar Fluid From Patients With Acute Respiratory Distress Syndrome Mediates the Inhibition of Monocyte Differentiation into Fibrocyte.
    Garnier M; Mailleux AA; Besnard V; Abback PS; Leçon V; Neuville M; Gouel A; Crestani B; Dehoux M; Quesnel C
    Crit Care Med; 2016 Jul; 44(7):e563-73. PubMed ID: 27002275
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Therapeutic time-window of a group IIA phospholipase A2 inhibitor in rabbit acute lung injury: correlation with lung surfactant protection.
    Furue S; Mikawa K; Nishina K; Shiga M; Ueno M; Tomita Y; Kuwabara K; Teshirogi I; Ono T; Hori Y; Matsukawa A; Yoshinaga M; Obara H
    Crit Care Med; 2001 Apr; 29(4):719-27. PubMed ID: 11373455
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Clinical and biological role of secretory phospholipase A2 in acute respiratory distress syndrome infants.
    De Luca D; Lopez-Rodriguez E; Minucci A; Vendittelli F; Gentile L; Stival E; Conti G; Piastra M; Antonelli M; Echaide M; Perez-Gil J; Capoluongo ED
    Crit Care; 2013 Jul; 17(4):R163. PubMed ID: 23883784
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Randomized controlled trial of volume-targeted synchronized ventilation and conventional intermittent mandatory ventilation following initial exogenous surfactant therapy.
    Mrozek JD; Bendel-Stenzel EM; Meyers PA; Bing DR; Connett JE; Mammel MC
    Pediatr Pulmonol; 2000 Jan; 29(1):11-8. PubMed ID: 10613781
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Effect of cooling on lung secretory phospholipase A2 activity in vitro, ex vivo, and in vivo.
    Autilio C; Shankar-Aguilera S; Minucci A; Touqui L; De Luca D
    Am J Physiol Lung Cell Mol Physiol; 2019 Mar; 316(3):L498-L505. PubMed ID: 30604626
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Effects of synchronized intermittent mandatory ventilation versus pressure support plus volume guarantee ventilation in the weaning phase of preterm infants*.
    Erdemir A; Kahramaner Z; Turkoglu E; Cosar H; Sutcuoglu S; Ozer EA
    Pediatr Crit Care Med; 2014 Mar; 15(3):236-41. PubMed ID: 24608494
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Lung Ultrasonography Score to Evaluate Oxygenation and Surfactant Need in Neonates Treated With Continuous Positive Airway Pressure.
    Brat R; Yousef N; Klifa R; Reynaud S; Shankar Aguilera S; De Luca D
    JAMA Pediatr; 2015 Aug; 169(8):e151797. PubMed ID: 26237465
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Randomized multicenter trial comparing synchronized and conventional intermittent mandatory ventilation in neonates.
    Bernstein G; Mannino FL; Heldt GP; Callahan JD; Bull DH; Sola A; Ariagno RL; Hoffman GL; Frantz ID; Troche BI; Roberts JL; Dela Cruz TV; Costa E
    J Pediatr; 1996 Apr; 128(4):453-63. PubMed ID: 8618177
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.